For patients who received 25 mg twice weekly throughout the study, the PASI 75 response continued to improve between weeks 12 and 36.
Patsiendi, kes said 25 mg kaks korda nädalas kogu uuringu vältel, jätkas PASI 75 vastus paranemist 12. ja 36. nädala vahel.